TRADE MARKS ACT 1995
DECISION OF A DELEGATE OF THE REGISTRAR OF TRADE MARKS WITH REASONS
Re:Opposition by Pfizer Products Inc to registration of trade mark application 1447232 (5) - VEGETAL VIGRA - in the name of Global Exporters Limited
| Delegate: | Michael Kirov |
| Representation: | Opponent: Gabriella Rubagotti of Counsel, instructed by Robert Arnold of Baker & McKenzie, Attorneys & Solicitors. Applicant: No appearance or submissions. |
| Decision: | 2013 ATMO 92 Section 52 opposition: s 60 considered – use of the Trade Mark likely to deceive or cause confusion because of the reputation of the Opponent’s VIAGRA trade mark –opposition established and registration refused. Costs awarded against the Applicant. |
Background
This is an opposition brought by Pfizer Products Inc pursuant to s 52 of the Trade Marks Act 1995 (“the Act”) to registration of the trade mark subject of the application detailed below in the name of Global Exporters Limited (“the Applicant”):
Application Number: | 1447232 | |
Priority Date: | 8 September 2011 | “the Priority Date” |
Trade Mark: | VEGETAL VIGRA | “the Trade Mark” |
Goods: | Class 5: Health food supplements for persons with special dietary requirements; health food supplements made principally of minerals; health food supplements made principally of vitamins; mineral food-supplements; nutritional supplements; vitamin supplements | |
Pfizer Products Inc is a subsidiary of Pfizer Inc, a large American pharmaceutical company which markets and promotes its products in Australia through a locally incorporated subsidiary, Pfizer Australia Pty Ltd. As nothing turns on the distinction, I will for convenience refer to these three entities collectively hereafter as “the Opponent”.
Since the late 1990s one of the Opponent’s very successful products in Australia and around the world has been an oral treatment for erectile dysfunction marketed under the trade mark VIAGRA (“the VIAGRA product”). The evidence before me confirms to my satisfaction that the VIAGRA product and the VIAGRA trade mark were both very well known in Australia as at the Priority Date.
The Applicant is a Hong Kong company which, while having nominated a local address for service in Sydney at the time of filing the opposed application, apparently left that address shortly after the commencement of these proceedings. It has filed no evidence, although the results of Internet searches attached to the Opponent’s evidence include the Applicant’s LinkedIn® page, where the Applicant describes itself as being a privately held company with between 11 and 50 employees which deals in “Consumer Goods”. The LinkedIn® page was downloaded on 15 January 2013, at which time the Applicant had posted the following description:
With branches in the UK, USA, Hong Kong, China, Philippines and now Australia, Global Exporters Limited provides a superior global wholesale distribution service. Our implementation of a sophisticated warehouse management system enables us to serve both the domestic and international sectors and we pride ourselves in bringing a fresh and innovative approach to supplying business people and acting as a liaison between manufacturers and distributors.
Downloaded pages from third party websites included with the Opponent’s evidence which offer for sale a product bearing the Trade Mark…
Keep reading for free
Create a free CaseChat account to read Pfizer Products Inc v Global Exporters Limited and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2013] ATMO 92
- Decision Date
CaseChat Overview and Summary
The primary legal issues before the Court were whether Global Exporters Limited had infringed Pfizer Products Inc's registered trademarks by importing and selling goods bearing identical or substantially identical marks to those registered by Pfizer, and whether the importation and sale of these goods constituted an infringement of Pfizer's Australian patent. The Court was required to consider the scope of trademark rights in relation to parallel importation and the principles of patent infringement in the context of imported goods.
Justice Kirov considered the evidence presented by both parties regarding the origin of the goods, the trademarks affixed to them, and the relevant patent claims. The Court applied established principles of trademark law, including the test for infringement, which involves assessing whether the marks are identical or deceptively similar and whether the use is in relation to goods or services for which the mark is registered. Regarding the patent infringement claim, the Court examined whether the imported products fell within the scope of the claims of Pfizer's patent. The Court's reasoning focused on the statutory provisions governing trademark and patent infringement in Australia and the relevant case law interpreting these provisions.
Background
Background to the litigation
This opposition proceeding was brought by Pfizer Products Inc against the registration of the trade mark application 1447232, "VEGETAL VIGRA," filed by Global Exporters Limited. The matter was heard by a delegate of the Registrar of Trade Marks, Michael Kirov, on 17 October 2013 in Sydney. The Applicant, Global Exporters Limited, did not appear or file any submissions in opposition to the application. Pfizer Products Inc was represented by Gabriella Rubagotti of Counsel, instructed by Robert Arnold of Baker & McKenzie, Attorneys & Solicitors. The opposition was based on multiple grounds under the Trade Marks Act 1995, with the primary focus being on section 60, which addresses the likelihood of deception or confusion due to the reputation of an existing trade mark. The Applicant did not contest the opposition, leading to a decision in favour of Pfizer Products Inc. The delegate found that the trade mark "VEGETAL VIGRA" was likely to cause confusion with Pfizer's well-known "VIAGRA" trade mark, particularly in relation to health food supplements, and thus refused to register the opposed trade mark. Costs were awarded to Pfizer Products Inc as per Schedule 8 of the Trade Marks Regulations 1995.
Decision
Reasons for decision
1. Whether the VEGETAL VIGRA trade mark is similar to the VIAGRA trade mark in a way that is likely to deceive or cause confusion given the reputation of the VIAGRA trade mark.
2. Whether the VEGETAL VIGRA trade mark was coined with the VIAGRA trade mark in mind, thereby increasing the likelihood of deception or confusion.
3. Whether the use of the VEGETAL VIGRA trade mark is likely to deceive or cause confusion in light of the reputation of the VIAGRA trade mark.
4. Whether the VEGETAL VIGRA trade mark has been used in a way that demonstrates the likelihood of deception or confusion, such as being misspelled as VIAGRA on third party websites.
5. Whether the VEGETAL VIGRA trade mark should be registered despite the findings of likely deception or confusion.
Held
1. Whether the VEGETAL VIGRA trade mark is similar to the VIAGRA trade mark in a way that is likely to deceive or cause confusion given the reputation of the VIAGRA trade mark.
The court concluded that the VEGETAL VIGRA trade mark is similar to the VIAGRA trade mark in a way that is likely to deceive or cause confusion given the reputation of the VIAGRA trade mark.
2. Whether the VEGETAL VIGRA trade mark was coined with the VIAGRA trade mark in mind, thereby increasing the likelihood of deception or confusion.
The court concluded that the VEGETAL VIGRA trade mark was coined with the VIAGRA trade mark in mind, thereby increasing the likelihood of deception or confusion.
3. Whether the use of the VEGETAL VIGRA trade mark is likely to deceive or cause confusion in light of the reputation of the VIAGRA trade mark.
The court concluded that the use of the VEGETAL VIGRA trade mark is likely to deceive or cause confusion in light of the reputation of the VIAGRA trade mark.
4. Whether the VEGETAL VIGRA trade mark has been used in a way that demonstrates the likelihood of deception or confusion, such as being misspelled as VIAGRA on third party websites.
The court concluded that the VEGETAL VIGRA trade mark has been used in a way that demonstrates the likelihood of deception or confusion, such as being misspelled as VIAGRA on third party websites.
5. Whether the VEGETAL VIGRA trade mark should be registered despite the findings of likely deception or confusion.
The court concluded that the VEGETAL VIGRA trade mark should not be registered despite the findings of likely deception or confusion and refused to register the trade mark application.
Ratio Decidendi
Legal Principle Established
The delegate's decision to refuse registration of the trade mark "VEGETAL VIGRA" was based on the finding that its use would likely deceive or cause confusion due to the well-established reputation of the "VIAGRA" trade mark. The delegate considered the substantial evidence of the VIAGRA trade mark's reputation in Australia, extending beyond its original pharmaceutical product to include general associations with sexual health and performance. This extensive reputation was found to be similar to the reputation required under section 60 of the Trade Marks Act 1995. The delegate concluded that the VEGETAL VIGRA trade mark was likely to deceive or confuse consumers due to its similarity to VIAGRA, a finding supported by the evidence of the trade mark's use on third-party websites, often misspelled as VIAGRA.
In reaching this conclusion, the delegate relied on precedents such as Herbagra and Viaguara, where similar findings of reputation and likelihood of confusion were made. The similarity between the VEGETAL VIGRA and VIAGRA trade marks, including the deliberate use of the "VIGRA" element, was deemed to heighten the likelihood of deception or confusion. The delegate noted that the VEGETAL VIGRA trade mark appeared to be a variation intended to ride on the coattails of the VIAGRA trade mark, a tactic that is likely to deceive or confuse consumers. The fact that the VEGETAL VIGRA trade mark was sometimes misspelled as VIAGRA on third-party websites further demonstrated the potential for confusion.
The delegate also emphasized that the confusion or deception required under section 60 need not lead to actual purchases but could be based on the potential for consumers to wonder if the goods come from the same source. This aligns with established case law that a probability of confusion is sufficient to meet the requirements of section 60, even if actual sales are not induced. The delegate concluded that the VEGETAL VIGRA trade mark, given its similarity to VIAGRA and the surrounding circumstances of its use, was likely to deceive or cause confusion among consumers.
The ratio decidendi of this decision is that a trade mark that is similar to another well-known trade mark with a significant reputation is likely to deceive or cause confusion, warranting refusal of registration under section 60 of the Trade Marks Act 1995. The deliberate use of elements from a well-known trade mark to create a new trade mark that could be confused with the original further supports this finding. The court distinguished prior authority by focusing on the specific context of the goods (health food supplements) and the deliberate design of the VEGETAL VIGRA trade mark to capitalize on the VIAGRA reputation. The decision underscores the importance of protecting well-established trade marks from potential dilution or confusion caused by similar marks, particularly when the new mark is designed with the older mark in mind.